Digital Pcr Based Precision Diagnostics Market
Digital PCR-Based Precision Diagnostics Market Forecasts to 2034 - Global Analysis By Product & Service (Digital PCR Instruments, Reagents & Consumables, Software & Data Analysis Solutions, Diagnostic Testing Services and Other Products & Services), Platform Type, Technology, Sample Type, Application, End User and By Geography
Market Dynamics:
Driver:
Increasing demand for high-sensitivity molecular diagnostics and precision oncology
Increasing demand for high-sensitivity molecular diagnostics and precision oncology is driving adoption of digital PCR-based precision diagnostics. Healthcare providers increasingly utilize digital PCR technologies for detecting rare genetic mutations, quantifying low-abundance nucleic acids, and monitoring disease-associated biomarkers. These technologies provide absolute molecular quantification and improved sensitivity for selected diagnostic applications. Growing adoption of liquid biopsy testing, expanding personalized medicine programs, and increasing investment in molecular diagnostics encourage utilization. Advances in automated sample processing and assay development further strengthen market growth.
Restraint:
High equipment costs and limited integration into routine diagnostic workflows
High equipment costs and limited integration into routine diagnostic workflows restrain adoption of digital PCR-based precision diagnostics. Advanced systems require specialized instruments, expensive consumables, validated reagents, and trained laboratory personnel. Differences in platform configurations and assay protocols complicate standardization across healthcare facilities. Limited reimbursement for certain molecular applications and competition from established quantitative PCR methods create additional barriers. Smaller diagnostic laboratories may face financial constraints when implementing high-throughput digital PCR testing infrastructure.
Opportunity:
Expansion of liquid biopsy diagnostics and multiplex digital PCR technologies
Expansion of liquid biopsy diagnostics and multiplex digital PCR technologies presents significant growth opportunities. Advanced platforms enable simultaneous detection of multiple genetic targets, improving molecular characterization and diagnostic efficiency. Digital PCR supports rare mutation analysis, circulating tumor DNA quantification, and monitoring of treatment-associated biomarkers. Growing demand for minimally invasive cancer testing and personalized therapeutic monitoring encourages innovation. Increasing investment in microfluidic systems, automated molecular workflows, and high-throughput testing platforms supports technological development.
Threat:
Competition from next-generation sequencing and evolving diagnostic regulations
Competition from next-generation sequencing and evolving diagnostic regulations poses significant challenges to digital PCR-based precision diagnostics. Advanced sequencing technologies provide broad molecular profiling capabilities, potentially reducing demand for targeted digital PCR applications. Differences in analytical performance, assay validation, and clinical interpretation can affect adoption. Increasing regulatory scrutiny and reimbursement uncertainty create commercialization barriers. Concerns regarding contamination, false-positive results, and laboratory workflow compatibility further compel manufacturers to demonstrate reliable clinical performance and cost-effectiveness.
Covid-19 Impact:
The COVID-19 pandemic increased demand for sensitive molecular testing and accelerated investment in nucleic acid detection technologies. Digital PCR gained attention for viral RNA quantification, assay validation, and research applications requiring high analytical sensitivity. However, supply chain disruptions, laboratory capacity constraints, and shifting healthcare priorities affected equipment availability and routine diagnostic services. Subsequent expansion of molecular laboratory infrastructure, renewed investment in infectious disease preparedness, and growing adoption of precision diagnostic technologies continue to support market development.
The reagents & consumables segment is expected to be the largest during the forecast period
The reagents & consumables segment is expected to account for the largest market share during the forecast period due to recurring demand for assay kits, master mixes, cartridges, chips, and droplet-generation materials. Digital PCR testing requires specialized consumables for sample partitioning, nucleic acid amplification, and molecular detection. Increasing diagnostic testing volumes, expanding laboratory installations, and growing adoption of precision oncology assays encourage consumption. Advances in standardized reagent formulations, multiplex assay compatibility, and automated sample preparation support segment growth.
The multiplex digital PCR segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the multiplex digital PCR segment is predicted to witness the highest growth rate due to increasing demand for simultaneous detection of multiple molecular targets. Multiplex assays improve testing efficiency by enabling analysis of several genetic variations or pathogens within a single reaction. Advances in fluorescence detection, assay design, and computational interpretation strengthen analytical capabilities. Growing investment in precision oncology, infectious disease diagnostics, and high-throughput molecular testing is expected to accelerate adoption.
Region with largest share:
During the forecast period, North America is expected to hold the largest share due to advanced molecular diagnostic infrastructure, substantial biotechnology investment, and extensive precision medicine activities. The United States leads regional development through diagnostic laboratories, academic research institutions, and healthcare organizations adopting digital PCR technologies. Increasing demand for liquid biopsy testing, established clinical research networks, and growing investment in molecular diagnostics encourage utilization. Technological innovation and partnerships between instrument manufacturers and healthcare providers strengthen regional commercialization.
Region with highest CAGR:
Over the forecast period, Asia Pacific is anticipated to exhibit the highest CAGR, supported by expanding molecular diagnostic infrastructure, increasing biotechnology investment, and growing demand for precision healthcare. China, Japan, India, South Korea, and Australia are advancing digital PCR research and diagnostic capabilities. Improving access to molecular testing, increasing cancer screening activities, and expanding infectious disease surveillance encourage adoption. Government healthcare initiatives and collaborations between diagnostic manufacturers and research institutions support regional growth.
Key players in the market
Some of the key players in the Digital PCR-Based Precision Diagnostics Market include Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., F. Hoffmann-La Roche Ltd., Sysmex Corporation, Standard BioTools Inc., Takara Bio Inc., Agilent Technologies, Inc., Merck KGaA, Danaher Corporation, JN Medsys Pte. Ltd., Combinati Inc., Formulatrix, Inc., Analytik Jena GmbH, Precigenome LLC, TargetingOne Corporation, RainSure Scientific, and JETA Molecular BV.
Key Developments:
In June 2026, QIAGEN N.V. announced an expansion of its QIAcuity digital PCR ecosystem, including planned gene expression assays, high-multiplex reagent solutions, enhanced automated analysis, and laboratory workflow integration. The developments aim to improve molecular quantification, standardize data interpretation, and expand digital PCR applications across research and biopharmaceutical laboratories.
In January 2026, QIAGEN N.V. outlined its digital PCR commercialization priorities, including expansion of the QIAcuity platform and automation capabilities. The initiative emphasizes product innovation, workflow efficiency, and broader adoption of digital PCR technologies across molecular research and diagnostic applications.
In July 2025, Bio-Rad Laboratories, Inc. announced the launch of four Droplet Digital PCR platforms, including the QX Continuum and QX700 series, following its acquisition of Stilla Technologies. The expanded portfolio supports advanced multiplexing, high-precision molecular quantification, and applications in oncology, infectious disease testing, and genetic research.
Products & Services Covered:
• Digital PCR Instruments
• Reagents & Consumables
• Software & Data Analysis Solutions
• Diagnostic Testing Services
• Other Products & Services
Platform Types Covered:
• Droplet-Based Digital PCR
• Chip-Based Digital PCR
• Nanoplate-Based Digital PCR
• Other Platform Types
Technologies Covered:
• Fluorescence-Based Digital PCR
• Multiplex Digital PCR
• High-Throughput Digital PCR
• Microfluidic Digital PCR
• Other Technologies
Sample Types Covered:
• Blood & Plasma
• Tissue & Biopsy Samples
• Urine
• Saliva & Respiratory Samples
• Cerebrospinal Fluid
• Other Sample Types
Applications Covered:
• Oncology & Liquid Biopsy Diagnostics
• Infectious Disease Diagnostics
• Genetic & Inherited Disorder Diagnostics
• Prenatal & Reproductive Genetic Testing
• Transplantation Monitoring
• Other Applications
End Users Covered:
• Hospitals & Clinics
• Diagnostic & Reference Laboratories
• Academic & Research Institutions
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)
• Other End Users
Regions Covered:
• North America
o United States
o Canada
o Mexico
• Europe
o United Kingdom
o Germany
o France
o Italy
o Spain
o Netherlands
o Belgium
o Sweden
o Switzerland
o Poland
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Thailand
o Malaysia
o Singapore
o Vietnam
o Rest of Asia Pacific
• South America
o Brazil
o Argentina
o Colombia
o Chile
o Peru
o Rest of South America
• Rest of the World (RoW)
o Middle East
Saudi Arabia
United Arab Emirates
Qatar
Israel
Rest of Middle East
o Africa
South Africa
Egypt
Morocco
Rest of Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations
2 Research Framework
2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
2.4.1 Data Collection (Primary and Secondary)
2.4.2 Data Modeling and Estimation Techniques
2.4.3 Data Validation and Triangulation
2.4.4 Analytical and Forecasting Approach
3 Market Dynamics and Trend Analysis
3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook
4 Competitive and Strategic Assessment
4.1 Porter's Five Forces Analysis
4.1.1 Supplier Bargaining Power
4.1.2 Buyer Bargaining Power
4.1.3 Threat of Substitutes
4.1.4 Threat of New Entrants
4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison
5 Global Digital PCR-Based Precision Diagnostics Market, By Product & Service
5.1 Digital PCR Instruments
5.2 Reagents & Consumables
5.2.1 Assay Kits & Master Mixes
5.2.2 Chips, Cartridges & Droplet Consumables
5.3 Software & Data Analysis Solutions
5.4 Diagnostic Testing Services
5.5 Other Products & Services
6 Global Digital PCR-Based Precision Diagnostics Market, By Platform Type
6.1 Droplet-Based Digital PCR
6.2 Chip-Based Digital PCR
6.3 Nanoplate-Based Digital PCR
6.4 Other Platform Types
7 Global Digital PCR-Based Precision Diagnostics Market, By Technology
7.1 Fluorescence-Based Digital PCR
7.2 Multiplex Digital PCR
7.3 High-Throughput Digital PCR
7.4 Microfluidic Digital PCR
7.5 Other Technologies
8 Global Digital PCR-Based Precision Diagnostics Market, By Sample Type
8.1 Blood & Plasma
8.2 Tissue & Biopsy Samples
8.3 Urine
8.4 Saliva & Respiratory Samples
8.5 Cerebrospinal Fluid
8.6 Other Sample Types
9 Global Digital PCR-Based Precision Diagnostics Market, By Application
9.1 Oncology & Liquid Biopsy Diagnostics
9.1.1 Rare Mutation Detection
9.1.2 Minimal Residual Disease (MRD) Monitoring
9.2 Infectious Disease Diagnostics
9.3 Genetic & Inherited Disorder Diagnostics
9.4 Prenatal & Reproductive Genetic Testing
9.5 Transplantation Monitoring
9.6 Other Applications
10 Global Digital PCR-Based Precision Diagnostics Market, By End User
10.1 Hospitals & Clinics
10.2 Diagnostic & Reference Laboratories
10.3 Academic & Research Institutions
10.4 Pharmaceutical & Biotechnology Companies
10.5 Contract Research Organizations (CROs)
10.6 Other End Users
11 Global Digital PCR-Based Precision Diagnostics Market, By Geography
11.1 North America
11.1.1 United States
11.1.2 Canada
11.1.3 Mexico
11.2 Europe
11.2.1 United Kingdom
11.2.2 Germany
11.2.3 France
11.2.4 Italy
11.2.5 Spain
11.2.6 Netherlands
11.2.7 Belgium
11.2.8 Sweden
11.2.9 Switzerland
11.2.10 Poland
11.2.11 Rest of Europe
11.3 Asia Pacific
11.3.1 China
11.3.2 Japan
11.3.3 India
11.3.4 South Korea
11.3.5 Australia
11.3.6 Indonesia
11.3.7 Thailand
11.3.8 Malaysia
11.3.9 Singapore
11.3.10 Vietnam
11.3.11 Rest of Asia Pacific
11.4 South America
11.4.1 Brazil
11.4.2 Argentina
11.4.3 Colombia
11.4.4 Chile
11.4.5 Peru
11.4.6 Rest of South America
11.5 Rest of the World (RoW)
11.5.1 Middle East
11.5.1.1 Saudi Arabia
11.5.1.2 United Arab Emirates
11.5.1.3 Qatar
11.5.1.4 Israel
11.5.1.5 Rest of Middle East
11.5.2 Africa
11.5.2.1 South Africa
11.5.2.2 Egypt
11.5.2.3 Morocco
11.5.2.4 Rest of Africa
12 Strategic Market Intelligence
12.1 Industry Value Network and Supply Chain Assessment
12.2 White-Space and Opportunity Mapping
12.3 Product Evolution and Market Life Cycle Analysis
12.4 Channel, Distributor, and Go-to-Market Assessment
13 Industry Developments and Strategic Initiatives
13.1 Mergers and Acquisitions
13.2 Partnerships, Alliances, and Joint Ventures
13.3 New Product Launches and Certifications
13.4 Capacity Expansion and Investments
13.5 Other Strategic Initiatives
14 Company Profiles
14.1 Bio-Rad Laboratories, Inc.
14.2 Thermo Fisher Scientific Inc.
14.3 QIAGEN N.V.
14.4 F. Hoffmann-La Roche Ltd.
14.5 Sysmex Corporation
14.6 Standard BioTools Inc.
14.7 Takara Bio Inc.
14.8 Agilent Technologies, Inc.
14.9 Merck KGaA
14.10 Danaher Corporation
14.11 JN Medsys Pte. Ltd.
14.12 Combinati Inc.
14.13 Formulatrix, Inc.
14.14 Analytik Jena GmbH
14.15 Precigenome LLC
14.16 TargetingOne Corporation
14.17 RainSure Scientific
14.18 JETA Molecular BV
List of Tables
1 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Region (2023-2034) ($MN)
2 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Product & Service (2023-2034) ($MN)
3 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Digital PCR Instruments (2023-2034) ($MN)
4 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Reagents & Consumables (2023-2034) ($MN)
5 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Assay Kits & Master Mixes (2023-2034) ($MN)
6 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Chips, Cartridges & Droplet Consumables (2023-2034) ($MN)
7 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Software & Data Analysis Solutions (2023-2034) ($MN)
8 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Diagnostic Testing Services (2023-2034) ($MN)
9 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Other Products & Services (2023-2034) ($MN)
10 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Platform Type (2023-2034) ($MN)
11 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Droplet-Based Digital PCR (2023-2034) ($MN)
12 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Chip-Based Digital PCR (2023-2034) ($MN)
13 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Nanoplate-Based Digital PCR (2023-2034) ($MN)
14 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Other Platform Types (2023-2034) ($MN)
15 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Technology (2023-2034) ($MN)
16 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Fluorescence-Based Digital PCR (2023-2034) ($MN)
17 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Multiplex Digital PCR (2023-2034) ($MN)
18 Global Digital PCR-Based Precision Diagnostics Market Outlook, By High-Throughput Digital PCR (2023-2034) ($MN)
19 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Microfluidic Digital PCR (2023-2034) ($MN)
20 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Other Technologies (2023-2034) ($MN)
21 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Sample Type (2023-2034) ($MN)
22 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Blood & Plasma (2023-2034) ($MN)
23 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Tissue & Biopsy Samples (2023-2034) ($MN)
24 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Urine (2023-2034) ($MN)
25 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Saliva & Respiratory Samples (2023-2034) ($MN)
26 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Cerebrospinal Fluid (2023-2034) ($MN)
27 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Other Sample Types (2023-2034) ($MN)
28 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Application (2023-2034) ($MN)
29 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Oncology & Liquid Biopsy Diagnostics (2023-2034) ($MN)
30 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Rare Mutation Detection (2023-2034) ($MN)
31 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Minimal Residual Disease (MRD) Monitoring (2023-2034) ($MN)
32 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Infectious Disease Diagnostics (2023-2034) ($MN)
33 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Genetic & Inherited Disorder Diagnostics (2023-2034) ($MN)
34 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Prenatal & Reproductive Genetic Testing (2023-2034) ($MN)
35 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Transplantation Monitoring (2023-2034) ($MN)
36 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Other Applications (2023-2034) ($MN)
37 Global Digital PCR-Based Precision Diagnostics Market Outlook, By End User (2023-2034) ($MN)
38 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)
39 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Diagnostic & Reference Laboratories (2023-2034) ($MN)
40 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Academic & Research Institutions (2023-2034) ($MN)
41 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Pharmaceutical & Biotechnology Companies (2023-2034) ($MN)
42 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Contract Research Organizations (CROs) (2023-2034) ($MN)
43 Global Digital PCR-Based Precision Diagnostics Market Outlook, By Other End Users (2023-2034) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY

We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.